What is the safety profile of upadacitinib across indications?

Jessica Farrell, PharmD, reviews a key study on the safety profile of upadacitinib in patients with RA, psoriatic arthritis, and atopic dermatitis. She highlights important findings on adverse events, including herpes zoster, serious infections, and cardiovascular risks. This Medication Review offers insights into the safety of upadacitinib based on 15,000+ patient-years of data, helping clinicians and patients make informed decisions.